Recently an important paper — one which had the potential to revolutionize the treatment of type 1 diabetes — was retracted because its results could not be replicated. Far from being a negative incident, this is the way that science should be done.
Having Type 1 diabetes means a person's insulin-producing beta cells don't work normally. New research brings us closer to the day that new, functional beta cells can be produced in the lab and given to diabetics to normalize their metabolism.
